Exploring The Role Of JAK Inhibitors In Managing Psoriatic Arthritis

Speciality: Rheumatology

Description:

A warm welcome to all the medical practitioners in this interesting session of understanding the role of  JAK inhibitors in managing psoriatic arthritis. 

Psoriatic arthritis is a chronic inflammatory arthritic disease. The patients undergo severe pain with psoriatic arthritis. Being a rheumatic disease it needs a proper attention to the inflammatory pathways or rather targeting inflammatory molecules which can alter the responses and help in getting a potential cure of the disease.

Psoriatic arthritis is a disease that has multiple manifestations comprising both musculoskeletal and non musculoskeletal manifestations. It is also associated with several comorbidities like cardiovascular, psychological, metabolic etc. 

The speakers Dr Bhupendra Vaishnav, Dr. Amit Sharma have provided elaborative knowledge on the immunological management of psoriatic disease with the use of JAK inhibitors.

Immunological pathways play a crucial role in disease management especially in the case of rheumatological disease. Managing rheumatoid arthritis often becomes difficult due to its rate of progression and associated health issues. 

The webinar will help in gaining important insights on JAK inhibiting drugs in controlling rheumatoid arthritis. JAK inhibitors work as a competitive inhibitor of JAK that binds to adenosine triphosphate in the kinase domain, which eventually helps in controlling rheumatoid arthritis. 

See More Webinars @ Hidoc Webinars